Studying Brugada Syndrome With an SCN1B Variants in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Ibrahim El‐Battrawy(University Hospitals of the Ruhr-University of Bochum), İbrahim Akın(University of Mannheim)
Cited by 35
Related Papers
Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials
|The Lancet|2023|194
TRPV1 activation and internalization is part of the LPS-induced inflammation in human iPSC-derived cardiomyocytes
|Scientific Reports|2021|29
Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screening
|Clinical and Translational Medicine|2021|22
Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry
|Journal of the American Heart Association|2023|17
Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
|Scientific Reports|2022|12